Raymont, Vanessa

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18 F-AV-45 (Flobetapir F 18)

Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., Dannals, R. F., Nandi, A., Brašić, J. R., Ye, W., et al. (2010) · Journal of Nuclear Medicine

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 684

Focal brain damage protects against post-traumatic stress disorder in combat veterans

Koenigs, M., Huey, E. D., Raymont, V., Cheon, B., Solomon, J., Wassermann, E. M., & Grafman, J. (2008) · Nature Neuroscience

Posttraumatic Stress Disorder ResearchTraumatic Brain Injury Research

Cited by 255

Distinct Regions of Prefrontal Cortex Mediate Resistance and Vulnerability to Depression

Koenigs, M., Huey, E. D., Calamia, M., Raymont, V., Tranel, D., & Grafman, J. (2008) · The Journal of Neuroscience

Neural and Behavioral Psychology StudiesTreatment of Major Depression

Cited by 243

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 130

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial

Creswell, C., Taylor, L., Giles, S., Howitt, S., Radley, L., Whitaker, E., Brooks, E., Knight, F., Raymont, V., Hill, C., et al. (2024) · The Lancet Psychiatry

Digital Mental Health InterventionsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 45

Artificial intelligence for dementia prevention

Newby, D., Orgeta, V., Marshall, C. R., Lourida, I., Albertyn, C. P., Tamburin, S., Raymont, V., Veldsman, M., Koychev, I., Bauermeister, S., et al. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare

Cited by 42

The inter-rater reliability of mental capacity assessments

Raymont, V., Buchanan, A., David, A. S., Hayward, P., Wessely, S., & Hotopf, M. (2007) · International Journal of Law and Psychiatry

Healthcare Decision-Making and RestraintsEthics and bioethics in healthcare

Cited by 38

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

Lanskey, J. H., Kocagoncu, E., Quinn, A. J., Cheng, Y.-J., Karadag, M., Pitt, J., Lowe, S., Perkinton, M., Raymont, V., Singh, K. D., et al. (2022) · BMJ Open

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 10

Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity

Lanskey, J. H., Jafarian, A., Karadag, M., Kocagoncu, E., Williams, R. S., Yadav, P., Quinn, A. J., Pitt, J., Thayanandan, T., Lowe, S., et al. (2025) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchNeural dynamics and brain function

Cited by 6